Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2024-10-31
2024-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Young Adults' Reactions to Low Nicotine Cigarette Advertising
NCT04906148
Evaluation of Very Low Nicotine Content Cigarettes in Adolescent Smokers
NCT02587312
Impact of Nicotine Reduction on Adolescent Cigarette Use, Alternative Tobacco Use, and Harm From Tobacco
NCT03860077
Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers
NCT02989038
Perceptions of Cigarette Smoking in Young Adults
NCT03953508
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Purple
Participants will receive cigarettes with intermediate or very low nicotine content in purple packaging
Nicotine content
Study-supplied cigarettes will contain either intermediate or very low nicotine content
White
Participants will receive cigarettes with intermediate or very low nicotine content in white packaging
Nicotine content
Study-supplied cigarettes will contain either intermediate or very low nicotine content
Black
Participants will receive cigarettes with intermediate or very low nicotine content in black packaging
Nicotine content
Study-supplied cigarettes will contain either intermediate or very low nicotine content
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nicotine content
Study-supplied cigarettes will contain either intermediate or very low nicotine content
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Are aged 18-25
* Report smoking ≥ 100 lifetime cigarettes
* Report smoking at least 1 non-menthol, filtered cigarette per day
Exclusion Criteria
* Plan to quit smoking in the next month
* Smoke menthol cigarettes \> 80% of the time
* Report consuming ≥ 25 alcohol-containing drinks per week
* Report a history or current psychiatric diagnosis or severe medical condition,
* Are color-blind or have another visual impairment (e.g., partial blindness, uncorrected cataract)
* Are pregnant and/or lactating
Additional, general reasons for exclusion include:
* Significant non-compliance with protocol and/or study design as determined by the Principal Investigator and/or Study Physician. Subjects may be deemed ineligible at any point throughout the study.
* Past, current, anticipated, or pending enrollment in another research program over the study period that could potentially impact subject safety, study data, and/or the study design as determined by the Principal Investigator and/or Study Physician.
* Any medical condition, illness, disorder, adverse event (AE), or concomitant medication that could compromise participant safety or significantly impact study performance as determined by the Principal Investigator and/or Study Physician. Subjects may be deemed ineligible for any of the aforementioned reasons at any point throughout the study, as well as during the initial telephone screen.
21 Years
29 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
National Cancer Institute (NCI)
NIH
Abramson Cancer Center at Penn Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Melissa Mercincavage
Research Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Melissa Mercincavage, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
829101
Identifier Type: OTHER
Identifier Source: secondary_id
UPCC 10021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.